A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants

NCT03491748 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ETX0282
DRUG: Cefpodoxime proxetil
DRUG: Placebo

Sponsor

Entasis Therapeutics